Australia’s top medical officer on Monday urged countrymen who have received an AstraZeneca COVID shot to “not delay” getting the second dose – even though the vaccine has been linked to more deaths than COVID in Australia this year.
Chief Medical Officer Paul Kelly, after a National Cabinet meeting, reiterated the benefits of vaccination and encouraged Australians to stay vigilant for symptoms of COVID-19. He told Australia’s ABC network that the benefits of the AstraZeneca vaccine in combating COVID-19 “far outweighed” the risks of developing a very rare blood clotting syndrome.
Two women in Australia have died from the blood clots. The only COVID fatality this year was an 80-year-old traveler who died in April after being infected overseas and diagnosed in hotel quarantine. Last week authorities recommended that the AstraZeneca vaccine be given only to people 60 or over; people 50-59 were encouraged to get the Pfizer vaccine instead.
Since the start of the pandemic, Australia, a country of 25 million people, has recorded just over 30,000 infections and 910 deaths.
? Today’s numbers: The U.S. has more than 33.5 million confirmed coronavirus cases and at least 601,800 deaths, according to Johns Hopkins University data. The global totals: More than 178.5 million cases and more than 3.86 million deaths. More than 149.6 million Americans have been fully vaccinated – nearly 45.1% of the population, according to the CDC.
? What we’re reading: Companies such as Moderna and Pfizer’s partner BioNTech, whose names are familiar from COVID-19 vaccines, are using mRNA to spur cancer patients’ bodies to make vaccines that will – they hope – prevent recurrences and treatments designed to fight off advanced tumors. Read the full story.
Keep refreshing this page for the latest updates. Want more? Sign up for our Coronavirus Watch newsletter for updates to your inbox and join our Facebook group.
Seeking to dispel fears, researchers at the University of Miami conducted a study to assess men’s fertility after COVID-19 vaccination and found no negative effects on their sperm.
From Dec. 17, 2020, to Jan. 12, 2021, they recruited 45 healthy volunteers ages 18 to 50 who were scheduled to get the Pfizer or Moderna vaccine, according to the study published in JAMA Network.
The participants were prescreened to ensure they had no previous or underlying fertility issues. Semen samples were taken before the first vaccine dose and approximately 70 days after the second, which is about how long sperm takes to regenerate.
Scientists analyzed semen volume, sperm concentration, sperm motility and total sperm count and found no significant decrease in any of these parameters compared with the samples taken before the COVID-19 shots.
“It was an unknown area that was making guys nervous to get the vaccine,” said study co-author Jesse Ory, urology fellow in infertility/andrology at the University of Miami Miller School of Medicine.
– Adrianna Rodriguez
COVID-19 deaths in the U.S. have dipped below 300 a day for the first time since the early days of the disaster in March 2020. The drive to put shots in arms also approached an encouraging milestone Monday: 150 million Americans fully vaccinated. The coronavirus was the third leading cause of death in the U.S. in 2020, behind heart disease and cancer, according to the Centers for Disease Control and Prevention. But CDC data suggests that more Americans now are dying every day from accidents, chronic lower respiratory diseases, strokes or Alzheimer’s disease than from COVID-19.
The Biden administration announced plans Monday to send 55 million COVID-19 vaccine doses overseas, part of its pledge to donate 80 million shots to other countries by the end of June. The U.S. will distribute about 41 million – about 75% – through the U.N.-backed global sharing COVAX initiative, which includes sending 14 million doses to Latin America and the Caribbean, about 16 million to Asia and about 10 million to Africa to be shared in coordination with the African Union, according to a fact sheet provided by the White House.
The rest of the 55 million doses will be sent directly to specific countries struggling with a pandemic surge, including Colombia, Argentina, Haiti, other Caribbean community countries, Afghanistan, Bangladesh, Pakistan, Indonesia, South Africa, Nigeria, Egypt, Iraq, Yemen, Tunisia, West Bank and Gaza and Ukraine.
The U.S. has already begun shipping 25 million doses of the 80 million President Joe Biden vowed to send abroad by the end of the month. The president joined G-7 leaders last week to announce a pledge to provide more than 1 billion additional COVID-19 vaccines globally, 500 million of which will come from the U.S.
– Courtney Subramanian
Some New England hospitals are rescheduling surgeries, citing a shortage of blood fueled by the pandemic. Periodic, localized blood shortages are not uncommon, but this shortage is “unprecedented in its scope,” said Dr. Claudia Cohn, chief medical officer for the American Association of Blood Banks. Officials point toward a number of factors including the typical summer drop in blood donations at a time when surgeries are increasing because of procedures that were postponed during the pandemic.
“We haven’t seen anything like this in about 30 or 40 years at least,” Dr. Vishesh Chhibber, director of transfusion medicine at UMass Memorial Health, told the Boston Globe.
U.S. borders with Mexico and Canada will remain closed “to reduce the spread” of COVID-19 through the end of July, the Department of Homeland Security announced on Twitter on Sunday. The agency, in conjunction with its Canadian and Mexican counterparts, originally closed the United States’ northern and southern borders to leisure travelers in March 2020 at the start of the COVID-19 pandemic. The restrictions have been extended on a monthly basis ever since, and were previously extended to July 21.
“Access for essential trade & travel” is still allowed, according to the DHS.
About 45% of the U.S. population is fully vaccinated against COVID-19 and cases are declining in a majority of states. But the spread of the highly contagious delta variant among the unvaccinated could pose a new threat, public health officials warn. The delta variant, first identified in India, now accounts up to 10% of cases in the United States.
The delta variant could trigger a surge in the fall if only 75% of the country’s population is vaccinated, former Food and Drug Administration chief Dr. Scott Gottlieb said Sunday on CBS’s “Face the Nation.”
About 45% of the U.S. population is fully vaccinated against COVID-19 and cases are declining in a majority of states. But the spread of the highly contagious delta variant among the unvaccinated could pose a new threat, public health officials warn. The delta variant, first identified in India, now accounts up to 10% of cases in the United States.
The delta variant could trigger a surge in the fall if only 75% of the country’s population is vaccinated, former Food and Drug Administration chief Dr. Scott Gottlieb said Sunday on CBS’s “Face the Nation.”
Department of International Relations and European Studies https://www.ibu.edu.ba/department-of-international-relations-and-european-studies/